UBS Group’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,206
Closed -$846 10328
2024
Q1
$846 Sell
1,206
-250
-17% -$282 ﹤0.01% 8342
2023
Q4
$2.55K Sell
1,456
-1,541
-51% -$2.25K ﹤0.01% 8095
2023
Q3
$4.32K Buy
2,997
+628
+27% +$1.57K ﹤0.01% 7451
2023
Q2
$6.16K Sell
2,369
-445
-16% -$1.33K ﹤0.01% 7390
2023
Q1
$10.4K Sell
2,814
-3,702
-57% -$15.6K ﹤0.01% 7590
2022
Q4
$11.5K Buy
6,516
+3,191
+96% +$8.49K ﹤0.01% 8386
2022
Q3
$13K Buy
3,325
+431
+15% +$2.65K ﹤0.01% 8087
2022
Q2
$16K Sell
2,894
-119,218
-98% -$976K ﹤0.01% 7226
2022
Q1
$1.79M Sell
122,112
-57,679
-32% -$772K ﹤0.01% 3538
2021
Q4
$2.84M Buy
179,791
+86,509
+93% +$2.08M ﹤0.01% 3418
2021
Q3
$3M Buy
93,282
+87,831
+1,611% +$3.09M ﹤0.01% 3208
2021
Q2
$226K Buy
5,451
+868
+19% +$35.7K ﹤0.01% 5257
2021
Q1
$233K Buy
4,583
+988
+27% +$51.7K ﹤0.01% 5373
2020
Q4
$117K Buy
3,595
+2,641
+277% +$37.4K ﹤0.01% 5585
2020
Q3
$11K Sell
954
-1,626
-63% -$18.8K ﹤0.01% 6793
2020
Q2
$34K Buy
2,580
+2,570
+25,700% +$33.5K ﹤0.01% 6193
2020
Q1
$0 Sell
10
-451
-98% -$5.54K ﹤0.01% 8532
2019
Q4
$6K Buy
+461
New +$4.04K ﹤0.01% 7543
2019
Q3
Sell
-90
Closed -$2K 8340
2019
Q2
$2K Sell
90
-3,759
-98% -$77.1K ﹤0.01% 7648
2019
Q1
$79K Buy
3,849
+3,749
+3,749% +$76.9K ﹤0.01% 5248
2018
Q4
$2K Hold
100
﹤0.01% 7823
2018
Q3
$2K Hold
100
﹤0.01% 7763
2018
Q2
$2K Hold
100
﹤0.01% 7748
2018
Q1
$2K Buy
+100
New +$1.96K ﹤0.01% 7569

Other funds holding DMTK

UBS Group's DMTK Position: Q2 2024 in Review

UBS Group sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 1,206 shares — an estimated $846 sold.

UBS Group first reported a position in DMTK in Q1 2018 and held it in 24 quarters. The position peaked at $3M in Q3 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • UBS Group reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • UBS Group sold 1,206 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $846.
  • UBS Group first reported a position in DermTech, Inc. Common Stock in Q1 2018 and held it in 24 quarters.
  • UBS Group's DermTech, Inc. Common Stock position peaked at $3M in Q3 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.